Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Adaptimmune
1315
Adaptimmune
Technology
Biotechnology
Adaptimmune is a multinational, clinical-stage #biotech company focused on developing novel immunotherapies that can potentially transform cancer treatment
Suggest edits
Type
B2c
Founded
2008
Raised
$42M
Follow us
Companies in the same industry
BioVex
Third Wave Technologies
enEvolv
Kythera Biopharma
SA Ignite
Wellpepper
FibroGen
Promethera Biosciences
Nirmidas Biotech
BG Medicine
Alexa global traffic share
Twitter followers
Overview
Funding
1
Add info
Latest funding
$42,000,000
Post-IPO equity - 2017
Team Size
50+
Employees
I work here
Location
United Kingdom
Headquarters
Explore United Kingdom
$42,000,000
Post-IPO equity
biospace
Adaptimmune Announces Closing Of 42 Million Registered Direct Offering
